MACF1 and non-small cell lung carcinoma: Notably, overexpression of circ_MACF1 decreased the IC50 value for gefitinib in A549/GR and PC9/GR cells (Fig. 2C, D), indicating that circ_MACF1 overexpression sensitized gefitinib-resistant NSCLC cells to gefitinib.